Streptococcus suis Serotype 2 in Pigs and Zoonotic Risk for Pork Workers: Meningitis and Diagnosis

Etiology and Taxonomic Classification

Streptococcus suis is a Gram-positive, facultatively anaerobic coccus belonging to the family Streptococcaceae. The organism typically appears in pairs or short chains under light microscopy and is catalase-negative. Based on capsular polysaccharide (CPS) antigens, 29 serotypes have been described (serotypes 1 through 34, with some serotypes reclassified or withdrawn). Among these, Streptococcus suis serotype 2 is the most frequently isolated serotype from diseased pigs worldwide and is the predominant serotype associated with human zoonotic infections [1].

The CPS of serotype 2 is a critical virulence determinant. The cps gene cluster encodes enzymes responsible for the biosynthesis of the polysaccharide capsule, which protects the bacterium from phagocytosis by host immune cells. Other key virulence-associated factors include muramidase-released protein (MRP), extracellular factor (EF), suilysin (SLY), and adhesins such as fibronectin-binding proteins. The presence of the mrp, epf, and sly genes is strongly linked to highly virulent strains, although the specific combination and expression levels vary across geographic regions [1, 2].

Epidemiology in Swine Populations

Streptococcus suis serotype 2 is an endemic pathogen in the global swine industry. The bacterium colonizes the upper respiratory tract, particularly the tonsils and nasal cavities, of healthy carrier pigs. Carrier rates in herds can exceed 80%, with piglets often acquiring the organism from sows during the early postnatal period [2].

Clinical disease occurs most commonly in nursery and early grower pigs, typically between 4 and 12 weeks of age. Disease outbreaks are frequently precipitated by stress factors such as weaning, mixing of litters, poor ventilation, high stocking density, and concurrent viral infections (e.g., porcine reproductive and respiratory syndrome virus or swine influenza virus). These stressors compromise mucosal immunity and facilitate bacterial translocation from the tonsils to the bloodstream, leading to septicemia and secondary localization to the meninges, joints, and serosal surfaces [1, 2].

The prevalence of virulent serotype 2 strains varies among countries. In some regions, serotype 2 is the dominant cause of porcine streptococcosis, while in others, serotypes 1/2, 3, 7, 9, and 14 are also commonly implicated. Understanding the local serotype distribution is important for vaccine formulation and diagnostic strategy.

Pathogenesis of Meningitis

The hallmark of invasive Streptococcus suis serotype 2 infection in pigs is meningitis. The pathogenesis of streptococcal meningitis involves a sequence of defined steps: colonization of the nasopharynx, invasion of the bloodstream, survival and multiplication in blood, penetration of the blood-brain barrier (BBB), and induction of inflammation within the central nervous system (CNS).

Hematogenous Dissemination

After colonizing the tonsillar epithelium, the bacteria invade through epithelial barriers via paracellular and transcellular routes. The capsule is essential for resisting opsonophagocytosis by neutrophils and macrophages. Suilysin, a cholesterol-dependent cytolysin, forms pores in host cell membranes, facilitating tissue invasion and promoting the release of pro-inflammatory cytokines [1].

Once in the bloodstream, S. suis serotype 2 can survive by evading complement deposition and antibody-mediated killing. Strains expressing high levels of MRP and EF exhibit increased survival in whole blood assays [2]. Bacteremia may be transient or sustained, with high bacterial loads correlating positively with the risk of CNS invasion.

Blood-Brain Barrier Penetration

The BBB is composed of brain microvascular endothelial cells (BMECs) joined by tight junctions. Streptococcus suis serotype 2 has been shown to adhere to and invade BMECs in vitro. The CPS and specific adhesins mediate binding to host cell receptors. Invasion occurs via a zipper-like mechanism involving cytoskeletal rearrangements dependent on host cell actin microfilaments. Once internalized, the bacteria can traverse the BMEC monolayer transcellularly without disrupting tight junction integrity [1].

Meningeal Inflammation

Following BBB penetration, bacteria multiply in the subarachnoid space. The presence of bacterial cell wall components, including lipoteichoic acid and peptidoglycan, triggers a robust inflammatory response. Resident microglia and infiltrating leukocytes release tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6. This inflammatory cascade increases BBB permeability, recruits additional leukocytes, and leads to cerebral edema, increased intracranial pressure, and neuronal damage. Clinically, this manifests as neurologic signs such as ataxia, circling, recumbency, nystagmus, and convulsions [1, 2].

Clinical Signs in Pigs

The clinical presentation of Streptococcus suis serotype 2 infection in pigs ranges from peracute death to chronic, localized disease. The most common forms are meningitis, arthritis, and septicemia.

Meningeal Form

This is the most frequently recognized clinical form in nursery pigs. Early signs include depression, anorexia, and pyrexia (40.0 to 42.0 degrees Celsius). Affected pigs often stand with a stiff gait, develop muscle tremors, and show hyperesthesia. As the disease progresses, neurologic deficits become apparent: paddling movements, opisthotonos, nystagmus, and blindness. Mortality in untreated cases can exceed 50% [2].

Septicemic Form

Septicemia is characterized by sudden death with few preceding clinical signs. Pigs found dead often exhibit cyanosis of the skin, particularly on the extremities and abdomen. This form is more common in younger pigs during the immediate post-weaning period.

Arthritic Form

Polyarthritis typically presents as lameness, swollen joints, and reluctance to stand. The carpal, tarsal, and stifle joints are most frequently affected. Arthritis may occur alone or in combination with meningitis.

Other Manifestations

Less commonly, S. suis serotype 2 can cause endocarditis, polyserositis (inflammation of the pleura, pericardium, and peritoneum), and pneumonia. Endocarditis, usually affecting the mitral or aortic valves, can lead to embolic showers and sudden death.

Zoonotic Risk for Pork Workers

Streptococcus suis serotype 2 is a recognized zoonotic pathogen with a significant occupational risk for pork workers. Individuals who handle live pigs, slaughter pigs, or process pork carcasses are at elevated risk of infection. The bacterium enters the human body through skin abrasions or cuts sustained during handling of infected pigs or contaminated pork products.

Clinical Presentation in Humans

In humans, S. suis serotype 2 most commonly causes meningitis and septicemia. The clinical syndrome closely mirrors that observed in pigs. Patients typically present with fever, severe headache, vomiting, and neck stiffness. Hearing loss is a frequent and often permanent sequela. Other complications include arthritis, endocarditis, and streptococcal toxic shock-like syndrome [1].

The mortality rate in human cases is lower than in swine, but morbidity remains high. In a proportion of survivors, permanent sensorineural deafness affects up to 50% of cases. Public health surveillance in Southeast Asian countries, where the disease is endemic, has identified S. suis as a leading cause of adult bacterial meningitis in pork-consuming populations [1].

Routes of Transmission

Transmission to humans is primarily occupational. Slaughterhouse workers, butchers, pig farmers, and transport workers are most at risk. Consumption of undercooked pork or raw pig blood products has been linked to foodborne cases in some regions. Person-to-person transmission is considered extremely rare.

Public Health Implications

The zoonotic risk is largely underdiagnosed due to the organism's fastidious growth characteristics and the lack of routine testing in clinical microbiology laboratories. In regions with intensive pig farming, occupational health programs should include education on the use of protective gloves, hand hygiene protocols, and prompt disinfection of wounds.

Gross Pathology and Histopathology

Necropsy findings in pigs with acute Streptococcus suis serotype 2 infection vary depending on the clinical form. In the meningeal form, the brain may appear grossly normal or show congestion of the meningeal vessels. The cerebrospinal fluid is often turbid due to the accumulation of neutrophils.

Histologically, a suppurative leptomeningitis is observed. The subarachnoid space is infiltrated with neutrophils, fibrin, and macrophages. Inflammatory cells may extend into the Virchow-Robin spaces and brain parenchyma (meningoencephalitis). Fibrin thrombi and endothelial activation are common [2].

In the arthritic form, joints contain an increased volume of viscous, turbid synovial fluid. Synovial membranes are hyperemic and thickened, with infiltration of neutrophils and fibrin deposition. In septicemic cases, widespread petechiae and ecchymoses are seen on serosal surfaces, lungs, and kidneys. Splenomegaly and lymphadenopathy are common.

Diagnostic Approaches

The diagnosis of Streptococcus suis serotype 2 infection requires a combination of clinical assessment, gross pathology, and confirmatory laboratory testing. Sampling site selection is critical; brain tissue, cerebrospinal fluid, joint fluid, and spleen are optimal specimens from affected pigs.

Conventional Culture and Biochemical Identification

Bacterial culture remains the foundation of diagnosis. Swabs or tissue samples are plated onto blood agar (supplemented with 5% sheep blood) and incubated under microaerophilic conditions at 35 to 37 degrees Celsius. Colony morphology after 18 to 24 hours appears as small, translucent, alpha-hemolytic colonies (partial green discoloration of the medium). Some serotype 2 strains may produce a narrow zone of beta-hemolysis.

Preliminary identification is based on Gram stain (Gram-positive cocci in pairs or short chains), catalase negativity, and the presence of Lancefield group D antigen. Biochemical characterization using commercial identification systems (e.g., API 20 Strep) can differentiate S. suis from other alpha-hemolytic streptococci, although definitive serotyping requires specific antiserum [2].

Serotyping

Capsular serotyping is essential for confirming serotype 2. Coagglutination or latex agglutination tests using serotype-specific antisera are widely used. These tests can be performed on isolated colonies directly. More recently, multiplex PCR assays targeting serotype-specific genes within the cps locus have been developed, enabling serotype determination from culture or directly from clinical specimens [1].

Molecular Detection by Polymerase Chain Reaction

PCR-based diagnostics offer high sensitivity and specificity, particularly for samples with low bacterial load or for samples from animals that have received prior antimicrobial therapy. A common target is the gdh gene, which encodes glutamate dehydrogenase and is conserved across all S. suis serotypes. For serotype-specific identification, PCR targeting the cps2J gene is used for serotype 2 [1].

A decision tree for diagnostic workup is provided below.

flowchart TD
    A[Clinical signs: neurologic, arthritic, septicemic], > B{Postmortem examination}
    B, > C[Collect brain, CSF, joint fluid, spleen]
    C, > D[Gram stain and culture on blood agar]
    D, > E{Alpha-hemolytic, Gram-positive cocci}
    E, > F[Catalase negative, optochin resistant]
    F, > G[Biochemical ID: API 20 Strep]
    G, > H{Confirm serotype 2}
    H, > I[Latex agglutination with serotype 2 antiserum]
    H, > J[Multiplex PCR for serotype-specific cps genes]
    I, > K[Positive identification]
    J, > K[Positive identification]
    K, > L[Antimicrobial susceptibility testing by broth microdilution]

Antimicrobial Susceptibility Testing

Antimicrobial resistance is a growing concern in S. suis serotype 2 isolates. Resistance to tetracyclines, macrolides, and lincomycin is widespread. Reduced susceptibility to penicillin and ceftiofur has been reported. Broth microdilution following standardized clinical breakpoints (e.g., those established for veterinary streptococci) is recommended. Susceptibility patterns should guide both individual animal treatment and herd-level antimicrobial policies.

Differential Diagnosis

Porcine meningitis can be caused by several agents. Key differentials for S. suis serotype 2 include Haemophilus parasuis (Glasser's disease), Mycoplasma hyorhinis, Actinobacillus suis, and Streptococcus equi subsp. zooepidemicus. Viral causes such as porcine encephalomyocarditis virus and rabies virus should also be considered in geographic areas where these pathogens are endemic. The arthritic form must be differentiated from Erysipelothrix rhusiopathiae (diamond skin disease) and Mycoplasma hyosynoviae. Bacterial culture and PCR are essential to distinguish these etiologies.

Treatment

Antimicrobial therapy must be initiated promptly, especially for pigs with clinical signs of meningitis. Due to the blood-brain barrier, high doses of antimicrobials with good CNS penetration are necessary. Penicillin G (20,000 to 40,000 IU/kg intramuscularly) is the drug of choice for susceptible isolates. Ceftiofur and amoxicillin are effective alternatives. However, the emergence of resistance mandates susceptibility testing for all clinical isolates [1, 2].

Supportive care including anti-inflammatory drugs (flunixin meglumine) and fluid therapy may improve survival rates in valuable animals. In acutely affected individuals, early aggressive treatment is critical; once severe neurologic signs are present, the prognosis is poor.

In cases of severe disease within a group, mass medication via water or feed may be considered for at-risk cohorts, but this should be guided by sensitivity data to avoid further selection of resistant strains.

Control and Prevention

Control of Streptococcus suis serotype 2 in swine herds relies on a multi-pronged approach encompassing biosecurity, management, and vaccination.

Biosecurity and Management

Reduction of stress is the single most important intervention. Practical measures include maintaining optimal stocking densities, ensuring adequate ventilation, controlling dust and ammonia levels, and minimizing temperature fluctuations. All-in/all-out management of nursery and finishing facilities reduces environmental contamination and breaks transmission cycles. Early weaning with segregated early weaning protocols can reduce the prevalence of carrier sows shedding the organism to their progeny [2].

Vaccination

Autogenous (herd-specific) bacterins are commonly used to control S. suis serotype 2 on farms with endemic disease. These vaccines are typically given to sows pre-farrowing to boost passive immunity in piglets, or to piglets directly after weaning. However, protection is variable and often serotype-specific. Cross-protection against other serotypes is limited because of capsular diversity.

Commercial bacterins containing serotype 2 are available in some regions. Research into subunit vaccines using conserved antigens such as suilysin and MRP is ongoing but has not yet resulted in widely available products with superior efficacy.

Antimicrobial Alternatives

The emergence of antimicrobial resistance has driven interest in non-antimicrobial control strategies. Probiotics (e.g., Lactobacillus spp.), organic acids, and essential oils have been investigated for their ability to modulate gut microbiota and reduce respiratory carrier rates. While some positive effects on growth performance have been observed, these products are not reliably effective at preventing acute outbreaks of meningitis.

References

[1] Gottschalk, M., & Segura, M. (2019). Streptococcus suis. In Pathogenesis of Bacterial Infections in Animals (5th ed.). Wiley-Blackwell.

[2] Staats, J. J., Feder, I., Okwumabua, O., & Chengappa, M. M. (1997). Streptococcus suis: past and present. Veterinary Research Communications, 21(6), 381-407.